164 related articles for article (PubMed ID: 19506324)
21. Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients.
Ito Y; Miyauchi A; Kihara M; Fukushima M; Higashiyama T; Miya A
World J Surg; 2018 Mar; 42(3):615-622. PubMed ID: 29349484
[TBL] [Abstract][Full Text] [Related]
22. Risk Factors for Lateral Neck Recurrence of N0/N1a Papillary Thyroid Cancer.
Kim Y; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2017 Nov; 24(12):3609-3616. PubMed ID: 28822118
[TBL] [Abstract][Full Text] [Related]
23. Sub-Classification of Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma by Pathologic Criteria.
Jeon MJ; Kim WG; Jang EK; Choi YM; Song DE; Sung TY; Yoon JH; Chung KW; Hong SJ; Ryu JS; Han JM; Kim TY; Shong YK; Kim WB
PLoS One; 2015; 10(7):e0133625. PubMed ID: 26186205
[TBL] [Abstract][Full Text] [Related]
24. Prognosis of low-risk papillary thyroid carcinoma patients: its relationship with the size of primary tumors.
Ito Y; Kudo T; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2012; 59(2):119-25. PubMed ID: 22068114
[TBL] [Abstract][Full Text] [Related]
25. The Effectiveness of Prophylactic Modified Neck Dissection for Reducing the Development of Lymph Node Recurrence of Papillary Thyroid Carcinoma.
Ito Y; Miyauchi A; Kudo T; Kihara M; Fukushima M; Miya A
World J Surg; 2017 Sep; 41(9):2283-2289. PubMed ID: 28429089
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
[TBL] [Abstract][Full Text] [Related]
27. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F
Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
[TBL] [Abstract][Full Text] [Related]
28. Level I lymph node involvement in patients with N1b papillary thyroid carcinoma: a prospective study.
Eweida AM; Sakr MF; Hamza Y; Khalil MR; Gabr E; Koraitim T; Al-Wagih HF; Abo-Elwafa W; Ezzat Abdel-Aziz T; Diab AA; El-Sabaa B; Nabawi AS
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1951-1958. PubMed ID: 27999997
[TBL] [Abstract][Full Text] [Related]
29. Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma.
Lei J; Zhong J; Jiang K; Li Z; Gong R; Zhu J
Oncotarget; 2017 Apr; 8(16):27022-27033. PubMed ID: 28223546
[TBL] [Abstract][Full Text] [Related]
30. The clinicopathologic differences of central lymph node metastasis in predicting lateral lymph node metastasis and prognosis in papillary thyroid cancer associated with or without Hashimoto's thyroiditis.
Zhu Y; Zheng K; Zhang H; Chen L; Xue J; Ding M; Wu K; Wang Z; Kong L; Chen X
Tumour Biol; 2016 Jun; 37(6):8037-45. PubMed ID: 26711787
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe.
Ito Y; Jikuzono T; Higashiyama T; Asahi S; Tomoda C; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
World J Surg; 2006 Oct; 30(10):1821-8. PubMed ID: 16983469
[TBL] [Abstract][Full Text] [Related]
32. Should Level V Be Routinely Dissected in N1b Papillary Thyroid Carcinoma?
Kim SK; Park I; Hur N; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2017 Feb; 27(2):253-260. PubMed ID: 27762727
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of lymph node ratio in metastatic papillary thyroid carcinoma.
Mansour J; Sagiv D; Alon E; Talmi Y
J Laryngol Otol; 2018 Jan; 132(1):8-13. PubMed ID: 29122022
[TBL] [Abstract][Full Text] [Related]
34. The Association Between Lymph Node Stage and Clinical Prognosis in Thyroid Cancer.
Zhang J; Cheng X; Shen L; Wang X; Wang L; Sun X; Qu S
Front Endocrinol (Lausanne); 2020; 11():90. PubMed ID: 32174889
[No Abstract] [Full Text] [Related]
35. Establishment of an intraoperative staging system (iStage) by improving UICC TNM classification system for papillary thyroid carcinoma.
Ito Y; Ichihara K; Masuoka H; Fukushima M; Inoue H; Kihara M; Tomoda C; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2010 Nov; 34(11):2570-80. PubMed ID: 20625728
[TBL] [Abstract][Full Text] [Related]
36. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
37. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.
Chow SM; Yau S; Kwan CK; Poon PC; Law SC
Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761
[TBL] [Abstract][Full Text] [Related]
38. Invasiveness and Metastatic Aggressiveness in Small Differentiated Thyroid Cancers: Demography of Small Papillary Thyroid Carcinomas in the Swedish Population.
Bayadsi H; Bergman M; Sund M; Hennings J
World J Surg; 2020 Feb; 44(2):461-468. PubMed ID: 31834455
[TBL] [Abstract][Full Text] [Related]
39. Patterns, predictive factors and prognostic impact of multilevel metastasis in N1b papillary thyroid carcinoma.
Kim SK; Park I; Hur N; Choe JH; Kim JH; Kim JS
Br J Surg; 2017 Jun; 104(7):857-867. PubMed ID: 28295219
[TBL] [Abstract][Full Text] [Related]
40. The effect of surgeon experience on the detection of metastatic lymph nodes in the central compartment and the pathologic features of clinically unapparent metastatic lymph nodes: what are we missing when we don't perform a prophylactic dissection of central compartment lymph nodes in papillary thyroid cancer?
Scherl S; Mehra S; Clain J; Dos Reis LL; Persky M; Turk A; Wenig B; Husaini H; Urken ML
Thyroid; 2014 Aug; 24(8):1282-8. PubMed ID: 24787362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
